Posted by DrJohn on 17 December, 2015 at 5:56 am. Be the first to comment!


A boyish drug company entrepreneur, who rocketed to infamy by jacking up the price of a life-saving pill from $13.50 to $750, was arrested by federal agents at his Manhattan home early Thursday morning on securities fraud related to a firm he founded.

Martin Shkreli, 32, ignited a firestorm over drug prices in September and became a symbol of defiant greed. The federal case against him has nothing to do with pharmaceutical costs, however. Prosecutors in Brooklyn charged him with illegally taking stock from Retrophin Inc., a biotechnology firm he started in 2011, and using it to pay off debts from unrelated business dealings. He was later ousted from the company, where he’d been chief executive officer, and sued by its board.

In the case that closely tracks that suit, federal prosecutors accused Shkreli of engaging in a complicated shell game after his defunct hedge fund, MSMB Capital Management, lost millions. He is alleged to have made secret payoffs and set up sham consulting arrangements. A New York lawyer, Evan Greebel, was also arrested early Thursday. He’s accused of conspiring with Shkreli in part of the scheme.

Shkreli’s lawyer and a spokesman for Retrophin didn’t immediately respond to requests for comment. Greebel and his firm weren’t immediately available to comment either. A spokeswoman for Brooklyn U.S. Attorney Robert Capers did not immediately respond to a call and e-mail seeking comment.
more at Bloomberg

0 0 votes
Article Rating
Would love your thoughts, please comment.x